Is This Robotics Firm a Giant In The Making?
Inside operating rooms across the globe, a revolution has been underway, one led by Intuitive Surgical (NASDAQ: ISRG).
Over the past five years, the company has more than doubled its profits, yet many argue that it’s still in the early innings of growth.
Key Points
-
Intuitive Surgical has more than doubled profits in five years.
» Read more about: Is This Robotics Firm a Giant In The Making? »
Read More
Why Stanley Druckenmiller Dumped AI Darling Palantir
Stanley Druckenmiller who famously helped George Soros break the Bank of England in 1992 has just ditched one of Wall Street’s most hyped artificial intelligence (AI) stocks.
So, what did he sell? Palantir Technologies (NYSE: PLTR). While most investors were busy chasing the AI boom, Druckenmiller was building a large position in a drugmaker.
» Read more about: Why Stanley Druckenmiller Dumped AI Darling Palantir »
Read More
Is AMC Entertainment Staging a Monster Comeback?
AMC Entertainment (NYSE: AMC) isn’t exactly the comeback kid just yet, but you might want to keep it on your radar.
Over the past month, shares have quietly climbed 14.96%, a surprising twist for a stock that’s still down more than 39% from last year and worse from its meme stock mania highs,
» Read more about: Is AMC Entertainment Staging a Monster Comeback? »
Read More
1 Monthly Dividend Stock To Never Stop Adding?
There’s something powerful, almost addictive, about waking up to income you didn’t have to actively work for. Passive income gives you more bang for your investment buck up front, and if you’ve chosen wisely, income producers raise their payouts over time, feeding a cycle of reinvestment and compounding that accelerates your path to financial independence.
» Read more about: 1 Monthly Dividend Stock To Never Stop Adding? »
Read More
Is This Healthcare Stock Set To Rally?
Eli Lilly has been a frustrating hold so far this year. Shares are slightly down year to date, a rare stumble for a company that has delivered nearly 5x returns over the past five years.
For a stock that’s become a poster child of the weight-loss and diabetes boom, the slowdown in momentum has left investors wondering if the story has run its course.
» Read more about: Is This Healthcare Stock Set To Rally? »
Read MoreThe Burst
Is Monday THE Operating System for Work?
Monday.com sits right in the middle of this transformation, and if management gets its way, it won’t just be a participant. It wants to be the work operating system for the modern enterprise.
For companies running cross-functional projects, think engineering, sales, marketing, and operations all under one roof, Monday offers a centralized dashboard where tasks can be assigned automatically,
» Read more about: Is Monday THE Operating System for Work? »
Read MoreThe Spotlight
Is Stellantis a Dividend Gem Hiding in Plain Sight?
Stellantis (NYSE: STLA) probably isn’t the first ticker that comes to mind when investors think “income stock.” But maybe it should be. The global auto giant, which straddles Italy, France, and the U.S. is delivering one of the highest dividend yields on the market today. It’s not just about the headline number, though. There’s a lot going on beneath the surface that most investors overlook—and some of it’s surprising.
» Read more about: Is Stellantis a Dividend Gem Hiding in Plain Sight? »
Read MoreThe Daily
22 mutual funds backed Lenskart’s steep IPO: One investor is asking why
An eyewear IPO at 12x revenue. A profit boosted by one-off gains. And yet, 147 anchor investors, including half of India’s mutual fund industry, lined up without hesitation.
That’s the scene around Lenskart’s public offering, and it’s triggered sharp criticism from investors.
SoftBank Group, Abu Dhabi Investment Authority,
» Read more about: 22 mutual funds backed Lenskart’s steep IPO: One investor is asking why »